1.Department of Pathology, Peking University Peoples Hospital, Beijing 100044, Peoples Republic of China; cdingbao@163.com
Tumours derived from Langerhans cells (LCs) are divided into two main subgroups, according to the degree of cytological atypia and clinical aggressiveness: LC histiocytosis (LCH) and LC sarcoma (LCS). LCS is a high-grade neoplasm with obviously malignant cytologic features and the Langerhans cell phenotype, which is rare. Here the clinic-pathological of LCS will be discussed based on reported cases in the literature.
Ding-Bao Chen
Langerhans cell sarcoma
Atlas Genet Cytogenet Oncol Haematol. 2019-11-01
Online version: http://atlasgeneticsoncology.org/haematological/1731/langerhans-cell-sarcoma